Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study

Fig. 3

Stratification analyses of CCND1 rs9344 and chemotherapy-induced overall toxicity in lung cancer patients. a–c Additive (a), dominant (b), and recessive (c) models with adjustments of age, sex, stage, histological type, smoking status, and chemotherapy regimens. Each box and horizontal line represent the odds ratio (OR) and 95% confidence interval (CI). NSCLC non-small cell lung carcinoma, ADC adenocarcinoma, SCC squamous cell carcinoma, SCLC small cell lung cancer. Regimen1, platinum + gemcitabine. Regimen2, platinum + etoposide. Regimen3, platinum + pemetrexed

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us